These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Halogenated derivatives QSAR model using spectral moments to predict haloacetic acids (HAA) mutagenicity. Pérez-Garrido A; González MP; Escudero AG Bioorg Med Chem; 2008 May; 16(10):5720-32. PubMed ID: 18406150 [TBL] [Abstract][Full Text] [Related]
43. Estimation of gas-phase reaction rate constants of alkylnaphthalenes with chlorine, hydroxyl and nitrate radicals. Long X; Niu J Chemosphere; 2007 May; 67(10):2028-34. PubMed ID: 17239921 [TBL] [Abstract][Full Text] [Related]
44. Mutagenicity of aromatic amines and amides with chemical models for cytochrome P450 in Ames assay. Inami K; Okazawa M; Mochizuki M Toxicol In Vitro; 2009 Sep; 23(6):986-91. PubMed ID: 19563884 [TBL] [Abstract][Full Text] [Related]
45. A comparison of alternative measures of mutagenic potency in the Salmonella (Ames) test. Horn L; Kaldor J; McCann J Mutat Res; 1983 May; 109(2):131-41. PubMed ID: 6843570 [TBL] [Abstract][Full Text] [Related]
47. Critical assessment of QSAR models of environmental toxicity against Tetrahymena pyriformis: focusing on applicability domain and overfitting by variable selection. Tetko IV; Sushko I; Pandey AK; Zhu H; Tropsha A; Papa E; Oberg T; Todeschini R; Fourches D; Varnek A J Chem Inf Model; 2008 Sep; 48(9):1733-46. PubMed ID: 18729318 [TBL] [Abstract][Full Text] [Related]
48. Quantitative structure-activity relationships of mutagenic aromatic and heteroaromatic azides and amines. Sabbioni G; Wild D Carcinogenesis; 1992 Apr; 13(4):709-13. PubMed ID: 1576721 [TBL] [Abstract][Full Text] [Related]
49. Mutagenicity of 2-[2-(acetylamino)-4-[bis(2-hydroxyethyl)amino]-5-methoxyphenyl]-5-amino-7-bromo-4-chloro-2H-benzotriazole (PBTA-6) and benzo[a]pyrene (BaP) in the gill and hepatopancreas of rpsL transgenic zebrafish. Amanuma K; Tone S; Nagaya M; Matsumoto M; Watanabe T; Totsuka Y; Wakabayashi K; Aoki Y Mutat Res; 2008 Oct; 656(1-2):36-43. PubMed ID: 18675378 [TBL] [Abstract][Full Text] [Related]
50. 3D QSAR comparative molecular field analysis on nonsteroidal farnesoid X receptor activators. Honório KM; Garratt RC; Polikarpov I; Andricopulo AD J Mol Graph Model; 2007 Mar; 25(6):921-7. PubMed ID: 17055759 [TBL] [Abstract][Full Text] [Related]
51. Quantitative structure-activity relationship of flavonoids for inhibition of heterocyclic amine mutagenicity. Hatch FT; Lightstone FC; Colvin ME Environ Mol Mutagen; 2000; 35(4):279-99. PubMed ID: 10861947 [TBL] [Abstract][Full Text] [Related]
52. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models. Bhongade BA; Gadad AK J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035 [TBL] [Abstract][Full Text] [Related]
53. Vibrational and photoionization spectroscopy of biomolecules: aliphatic amino acid structures. Hu Y; Bernstein ER J Chem Phys; 2008 Apr; 128(16):164311. PubMed ID: 18447443 [TBL] [Abstract][Full Text] [Related]
54. The introduction of the Salmonella/microsome mutagenicity assay in a groundwater monitoring program. Valente-Campos S; Dias CL; Barbour ED; de Souza Nascimento E; de Aragão Umbuzeiro G Mutat Res; 2009 Apr; 675(1-2):17-22. PubMed ID: 19386242 [TBL] [Abstract][Full Text] [Related]
55. Prediction of mutagenic activity of nitronaphthalene isomers by infrared and Raman spectroscopy. Librando V; Alparone A J Hazard Mater; 2008 Jun; 154(1-3):1158-65. PubMed ID: 18093730 [TBL] [Abstract][Full Text] [Related]
56. A strategy for ranking environmentally occurring chemicals. Part VI. QSARs for the mutagenic effects of halogenated aliphatics. Eriksson L; Hellberg S; Johansson E; Jonsson J; Sjöström M; Wold S; Berglind R; Karlsson B Acta Chem Scand (Cph); 1991 Oct; 45(9):935-44. PubMed ID: 1793683 [TBL] [Abstract][Full Text] [Related]
57. The mutagenic hazards of environmental PM2.5 in Turin. Gilli G; Pignata C; Schilirò T; Bono R; La Rosa A; Traversi D Environ Res; 2007 Feb; 103(2):168-75. PubMed ID: 17007834 [TBL] [Abstract][Full Text] [Related]